Implants

Synapse Dental Pain Eraser Receives 2023 Cellerant Best of Class Hygiene Award for Setting a New Standard of Patient Care in Dentistry

CRANSTON, R.I., July 12, 2023 (GLOBE NEWSWIRE) -- The Synapse Dental Pain Eraser – the world’s first pen-shaped, portable, electronic…

12 months ago

IMPLANET Reports Revenue of €4.3 Million in the First Half of 2023

Q2 2023 revenue of €2.1 million, stable compared with Q2 2022 Continuation of the sales momentum for the new Medical…

12 months ago

The Orthopaedic Implant Company Announces Commercial Launch of the Innovative Threaded Metacarpal Nail System

Revolutionizing Hand Fracture Care with a Best-in-Breed Approach to Metacarpal FixationRENO, NV / ACCESSWIRE / July 11, 2023 / The…

12 months ago

Agile Sees Renewed Hope For Even Broader Adoption Of Its Weekly Birth Control Patch After Biden’s Latest Executive Order Expanding Contraceptive Coverage

PRINCETON, NJ / ACCESSWIRE / July 11, 2023 / - In June, President Biden issued an Executive Order on Strengthening…

12 months ago

Safe group group reports half-year revenues of €2.9m

                                                                                                                                                    Safe group group reports half-year revenues of €2.9m      Second-quarter revenue of €1.4M in Q2 2022, stable compared with Q1…

12 months ago

Aurora Spine Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study

Carlsbad, Calif, June 28, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a…

1 year ago

OrthoPediatrics Corp. Announces the Launch and First Case Using the GIRO™ Growth Modulation System

WARSAW, Ind., June 27, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively…

1 year ago

Femasys Announces FDA Approval of its IDE for the Pivotal Clinical Trial of FemBloc Permanent Birth Control, a Non-Surgical Alternative for Women

- Pivotal clinical trial to begin in the third quarter of 2023 - ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Sientra Announces Appointment of Alexander W. Casdin to Board of Directors

IRVINE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company…

1 year ago

Lyra Therapeutics to Present at Jefferies Healthcare Conference

WATERTOWN, Mass., June 02, 2023 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage biotechnology company developing innovative therapies…

1 year ago